BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 9125381)

  • 1. Defective viral vectors as agents for gene transfer in the nervous system.
    Kaplitt MG; Makimura H
    J Neurosci Methods; 1997 Jan; 71(1):125-32. PubMed ID: 9125381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of high-titer defective HSV-1 vectors using an IE 2 deletion mutant and quantitative study of expression in cultured cortical cells.
    Lim F; Hartley D; Starr P; Lang P; Song S; Yu L; Wang Y; Geller AI
    Biotechniques; 1996 Mar; 20(3):460-9. PubMed ID: 8679207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple immediate-early gene-deficient herpes simplex virus vectors allowing efficient gene delivery to neurons in culture and widespread gene delivery to the central nervous system in vivo.
    Lilley CE; Groutsi F; Han Z; Palmer JA; Anderson PN; Latchman DS; Coffin RS
    J Virol; 2001 May; 75(9):4343-56. PubMed ID: 11287583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene delivery using herpes simplex virus vectors.
    Burton EA; Fink DJ; Glorioso JC
    DNA Cell Biol; 2002 Dec; 21(12):915-36. PubMed ID: 12573050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adeno-associated virus vectors and neurological gene therapy.
    Ojala DS; Amara DP; Schaffer DV
    Neuroscientist; 2015 Feb; 21(1):84-98. PubMed ID: 24557878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors.
    Fraefel C; Jacoby DR; Lage C; Hilderbrand H; Chou JY; Alt FW; Breakefield XO; Majzoub JA
    Mol Med; 1997 Dec; 3(12):813-25. PubMed ID: 9440115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral vector systems for gene therapy.
    Jolly D
    Cancer Gene Ther; 1994 Mar; 1(1):51-64. PubMed ID: 7621239
    [No Abstract]   [Full Text] [Related]  

  • 8. An efficient deletion mutant packaging system for defective herpes simplex virus vectors: potential applications to human gene therapy and neuronal physiology.
    Geller AI; Keyomarsi K; Bryan J; Pardee AB
    Proc Natl Acad Sci U S A; 1990 Nov; 87(22):8950-4. PubMed ID: 2174168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herpes simplex virus vectors for gene therapy.
    Latchman DS
    Mol Biotechnol; 1994 Oct; 2(2):179-95. PubMed ID: 7866875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minireview: the herpes simplex virus amplicon--a versatile defective virus vector.
    Frenkel N; Singer O; Kwong AD
    Gene Ther; 1994; 1 Suppl 1():S40-6. PubMed ID: 8542394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene transfer with herpes simplex vectors.
    Lachmann RH; Efstathiou S
    Curr Opin Mol Ther; 1999 Oct; 1(5):622-32. PubMed ID: 11249669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene delivery to neurons: is herpes simplex virus the right tool for the job?
    Leib DA; Olivo PD
    Bioessays; 1993 Aug; 15(8):547-54. PubMed ID: 8135768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infection of cultured central nervous system neurons with a defective herpes simplex virus 1 vector results in stable expression of Escherichia coli beta-galactosidase.
    Geller AI; Freese A
    Proc Natl Acad Sci U S A; 1990 Feb; 87(3):1149-53. PubMed ID: 2153970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LacZ gene transfer to skeletal muscle using a replication-defective herpes simplex virus type 1 mutant vector.
    Huard J; Akkaraju G; Watkins SC; Pike-Cavalcoli M; Glorioso JC
    Hum Gene Ther; 1997 Mar; 8(4):439-52. PubMed ID: 9054519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adeno-associated viral vectors for gene transfer and gene therapy.
    Büeler H
    Biol Chem; 1999 Jun; 380(6):613-22. PubMed ID: 10430026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene transfer to the nigrostriatal system by hybrid herpes simplex virus/adeno-associated virus amplicon vectors.
    Costantini LC; Jacoby DR; Wang S; Fraefel C; Breakefield XO; Isacson O
    Hum Gene Ther; 1999 Oct; 10(15):2481-94. PubMed ID: 10543613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
    Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
    Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The herpes simplex virus amplicon: a new eucaryotic defective-virus cloning-amplifying vector.
    Spaete RR; Frenkel N
    Cell; 1982 Aug; 30(1):295-304. PubMed ID: 6290080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpesvirus-based infectious titering of recombinant adeno-associated viral vectors.
    Mohiuddin I; Loiler S; Zolotukhin I; Byrne BJ; Flotte TR; Snyder RO
    Mol Ther; 2005 Feb; 11(2):320-6. PubMed ID: 15668144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient gene transfer to neurons and glia: analysis of adenoviral vector performance in the CNS and PNS.
    Hermens WT; Giger RJ; Holtmaat AJ; Dijkhuizen PA; Houweling DA; Verhaagen J
    J Neurosci Methods; 1997 Jan; 71(1):85-98. PubMed ID: 9125378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.